View drug registration information details.


ItemsRegistration information
ID1245
No1245
Brand NameCIPRULZ DRY SUSPENSION 125MG/5 ML
IngredientsCIPROFLOXACIN AS (HCL) 125 MG/5ML
Dosage FormPOWDER FOR SUSPENSION
Primary PackagingBottle
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack Size60ML/BOTTLE/BOX
Dispensing CategoryPrescription only
ATC ClassificationJ03CB03
Pharmaceutical ClassANTIBACTERIA
IndicationsLOWER RESPIRATORY TRACT INFECTION DUE TO GRAM-NEGATIVE BACTERIA, CHRONIC SUPPURATIVE OTITIS MEDIA, URINARY TRACT INFECTION, GENITAL TRACT INFECTION,INTRA-ABDOMINAL INFECTION, INFECTION OF THE SKIN AND SOFT TISSUE…
ContraindicationsHYPERSENSITIVITY, CONCOMITANT ADMINISTRATION OF CIPROFLOXACIN AND TIZANIDINE
Side EffectsNAUSEA, DIARRHEA, DECREASED APPETITE, HEADACHE, DIZZINESS, SLEEP DISORDERS, TASTE DISORDERS
Unit Price0.70$
EDL Yes
DescriptionOFF WHITE GRANULAR POWDER, OFF WHITE COLORED VISCOUS SUSPENSION HAVING BANANA FLAVOR, VISUALLY FREE FROM FOREIGN PARTICLES AFTER RECONSTITUTION.
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerFOCUS & RULZ PHARMACEUTICALS (PVT) LTD
CountryPAKISTAN
Import Registration No68892
Import Registration Date2011-03-26
ActivityCERTIFICATE RELEASED
Applied Date2022-06-08
FDD Registration No06 I 4739/19
FDD Registration Date2022-09-26
Expiry Date2025-09-25

Back to drug list